NORGES BANK - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
NORGES BANK ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$65,410,322
+257.4%
960,504
+67.7%
0.02%
+240.0%
Q2 2022$18,300,800
-0.2%
572,795
+8.2%
0.01%
+25.0%
Q1 2022$18,344,998
+210.1%
529,590
+162.0%
0.00%
+300.0%
Q4 2021$5,916,000
-36.9%
202,121
-45.0%
0.00%
-50.0%
Q3 2021$9,371,000
-27.2%
367,7780.0%0.00%
-33.3%
Q2 2021$12,880,000
-29.4%
367,778
-17.9%
0.00%
-25.0%
Q1 2021$18,245,000
-24.0%
447,726
-19.2%
0.00%
-33.3%
Q4 2020$24,006,000
-20.9%
554,284
+0.7%
0.01%
-25.0%
Q3 2020$30,357,000
-11.4%
550,540
+1.4%
0.01%
-20.0%
Q2 2020$34,281,000
+5.0%
543,023
-15.0%
0.01%
-16.7%
Q1 2020$32,651,000
-35.7%
639,0820.0%0.01%
-14.3%
Q4 2019$50,801,000
+67.3%
639,082
+2.1%
0.01%
+55.6%
Q3 2019$30,368,000
-7.8%
625,8920.0%0.01%
-10.0%
Q2 2019$32,922,000
+13.3%
625,892
+14.0%
0.01%
+11.1%
Q1 2019$29,056,000
+63.0%
548,949
+26.4%
0.01%
+28.6%
Q4 2018$17,826,000
+79.2%
434,259
+65.9%
0.01%
+133.3%
Q3 2018$9,945,000
-15.9%
261,6950.0%0.00%
-25.0%
Q2 2018$11,829,000
-2.3%
261,695
+4.4%
0.00%0.0%
Q1 2018$12,104,000
+1031.2%
250,608
+415.7%
0.00%
+300.0%
Q3 2016$1,070,000
+7.5%
48,600
-19.0%
0.00%
Q2 2016$995,00060,0000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 460,000$14,872,00013.19%
VHCP Management II, LLC 141,611$4,578,0003.76%
Perceptive Advisors 1,186,630$38,363,0002.84%
RTW INVESTMENTS, LP 175,156$5,663,0001.87%
Casdin Capital, LLC 65,000$2,101,0001.86%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,163,811$37,626,0001.52%
RA Capital Management 457,142$14,779,0001.46%
VHCP Management, LLC 60,691$1,962,0001.19%
Iguana Healthcare Management, LLC 110,000$3,556,0001.17%
Partner Investment Management, L.P. 15,634$505,0000.83%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders